Compare AU
Compare GHHF vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Wealthbuilder All Gr Geared Complex ETF (GHHF) and the BetaShares Global Healthcare ETF - Currency Hedged (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
GHHF | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 98 | 63 |
Median incremental investment | $2,028.52 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $4,668.60 | $1,882.65 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
GHHF | DRUG | |
|---|---|---|
Strategy | GHHF.AX was created on 2024-04-19 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. GHHF.AX seeks to help investors build long-term wealth by providing a cost-effective way to benefit from moderately geared exposure to the returns of a diversified portfolio of Australian and global equities. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | BETASHARES GLOBAL SHARES ETF (56.27 %) BETASHARES AUSTRALIA 200 ETF (54.71 %) BETASHARES GLOBAL SHARES ETF C (29.16 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0.35 % | 0.57 % |
Key Summary
GHHF | DRUG | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | |
Asset class | ETF | ETF |
Management fee | 0.35 % | 0.57 % |
Price | $30.05 | $8.15 |
Size | N/A | $182.401 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 0.23 % | 1.90 % |
Market | ASX | ASX |
First listed date | 22/04/2024 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
GHHF | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 98 | 63 |
Median incremental investment | $2,028.52 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $4,668.60 | $1,882.65 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
GHHF | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
GHHF | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |